|
Volumn 35, Issue 3, 2008, Pages 387-393
|
The risk of hospitalized infection in patients with rheumatoid arthritis
a b,c d e f a a,g
g
i3DrugSafety
*
(United States)
|
Author keywords
Biologics; Disease modifying antirheumatic drugs; Infection; Rheumatoid arthritis
|
Indexed keywords
ADALIMUMAB;
ANTIBIOTIC AGENT;
AURANOFIN;
AUROTHIOGLUCOSE;
AUROTHIOMALATE;
AZATHIOPRINE;
CORTICOSTEROID;
CYCLOOXYGENASE 2 INHIBITOR;
CYCLOPHOSPHAMIDE;
CYCLOSPORIN;
DISEASE MODIFYING ANTIRHEUMATIC DRUG;
ETANERCEPT;
HYDROXYCHLOROQUINE;
INFLIXIMAB;
LEFLUNOMIDE;
METHOTREXATE;
NONSTEROID ANTIINFLAMMATORY AGENT;
PENICILLAMINE;
RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT;
SALAZOSULFAPYRIDINE;
TACROLIMUS;
ADULT;
AGED;
ARTICLE;
BACTERIAL INFECTION;
COHORT ANALYSIS;
CONTROLLED STUDY;
DATA BASE;
FEMALE;
HOSPITAL INFECTION;
HUMAN;
INFECTION RISK;
MAJOR CLINICAL STUDY;
MALE;
MYCOSIS;
PATHOGENESIS;
PNEUMONIA;
PRIORITY JOURNAL;
RHEUMATOID ARTHRITIS;
SEPSIS;
SKIN INFECTION;
TUBERCULOSIS;
URINARY TRACT INFECTION;
ADOLESCENT;
ADRENAL CORTEX HORMONES;
ADULT;
AGED;
ANTIRHEUMATIC AGENTS;
ARTHRITIS, RHEUMATOID;
CASE-CONTROL STUDIES;
COHORT STUDIES;
CROSS INFECTION;
DATABASES, FACTUAL;
DOSE-RESPONSE RELATIONSHIP, DRUG;
FEMALE;
HUMANS;
MALE;
MIDDLE AGED;
RETROSPECTIVE STUDIES;
RISK;
|
EID: 40649111668
PISSN: 0315162X
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (248)
|
References (43)
|